Content about Collaborative Care

BASKING RIDGE, N.J. — Mylan Specialty announced Thursday the introduction of a "$0 Co-Pay Offer" on a product used to treat severe allergic reactions.

The drug maker is offering a co-pay card to patients with or without insurance for the EpiPen in recognition of the 25th anniversary of its approval by the Food and Drug Administration. The co-pay card is available online at EpiPen.com, and the offer will expire on Dec. 31.

WASHINGTON — The House Committee on Energy and Commerce Subcommittee on Health heard testimony on Thursday morning from representatives of the Food and Drug Administration and several industry trade groups following the introduction of draft legislation that sponsors said would strengthen the country's pharmaceutical supply chain.

BETHESDA, Md. — The Food and Drug Administration has approved a new drug for constipation related to use of opioid painkillers made by Sucampo Pharmaceuticals and Takeda Pharmaceuticals, the drug makers said.

CHICAGO — Generic drug maker Hospira marked its fifth year marketing knock-off versions of biotech drugs in Europe Wednesday as it presented at the 2013 Biotechnology Industry Organization International Convention this week.

The drug maker said it delivered more than 5 million doses of biosimilar medicines to patients in Europe and Australia. The convention includes multiple sessions devoted to such topics as biosimilar regulatory approval, manufacturing and market formation, the company said.

NEW YORK — A dramatic jump in the rates of misuse of prescription stimulants over the past four years is linked to lax attitudes on the part of parents, according to a new study, though misuse and abuse of prescription opioids has remained flat.

FRANKLIN LAKES, N.J. — The Food and Drug Administration has approved a second product in BD's new line of injectable drugs, the company said Tuesday.

BD Rx, the pharmaceutical arm of the medical technology manufacturer, whose name stands for Becton, Dickinson and Co., received FDA approval for metoclopramide, part of its BD Simplist line of ready-to-administer pre-filled generic injectables. The product is an antiemetic, a drug used to stop vomiting.

HOFFMAN ESTATES, Ill. — An armed robber allegedly stole sensitive electronic information on pharmacy customers from a Kmart store in Little Rock, Ark., last month, the mass merchandise retailer said.

PRINCETON, N.J. — Sandoz U.S. Generics Operating Unit VP sales and marketing Rich Tremonte will leave the company.

The company said Tremonte would be working for AmerisourceBergen Corp. as VP global generic pharmaceuticals starting on June 1.

DUBLIN — The Food and Drug Administration has approved a new contraceptive drug made by Warner Chilcott, the drug maker said.

Warner Chilcott announced the approval of Minastrin 24 FE (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules) for prevention of pregnancy.

The drug maker said an unnamed third-party company would manufacture the drug, but it did not expect to launch it this year.

BASEL, Switzerland — The Food and Drug Administration has approved a drug made by Alcon, the drug maker said.

CAMP HILL, Pa. — Rite Aid's revamped website will offer a "more personalized and engaging" experience for customers, the company said Monday.

The new site, which it worked with Razorfish Healthware to design, includes easier access to online pharmacy services, health and wellness information.

ALAMEDA, Calif. — Abbott Diabetes Care earlier this week initiated a voluntary recall of its FreeStyle lnsulinx Blood Glucose Meters in the United States.

"Our first priority is to safeguard the health and safety of patients," stated Heather Mason, SVP Diabetes Care, Abbott. "We are committed to ensuring that our customers are able to continue to test their blood glucose with confidence, and we initiated this voluntary recall to ensure our products continue to meet the highest standards of quality and safety."